NO20090554L - Farmasoytiske preparater av memantin - Google Patents
Farmasoytiske preparater av memantinInfo
- Publication number
- NO20090554L NO20090554L NO20090554A NO20090554A NO20090554L NO 20090554 L NO20090554 L NO 20090554L NO 20090554 A NO20090554 A NO 20090554A NO 20090554 A NO20090554 A NO 20090554A NO 20090554 L NO20090554 L NO 20090554L
- Authority
- NO
- Norway
- Prior art keywords
- memantine
- pharmaceutical preparations
- relates
- compositions
- pharmaceutical
- Prior art date
Links
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004640 memantine Drugs 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000007941 film coated tablet Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81882306P | 2006-07-05 | 2006-07-05 | |
| PCT/US2006/036628 WO2008005036A1 (en) | 2006-07-05 | 2006-09-20 | Pharmaceutical compositions of memantine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090554L true NO20090554L (no) | 2009-02-04 |
Family
ID=37440592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090554A NO20090554L (no) | 2006-07-05 | 2009-02-04 | Farmasoytiske preparater av memantin |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080008752A1 (pt) |
| EP (1) | EP1886670A1 (pt) |
| JP (1) | JP2009542647A (pt) |
| KR (1) | KR20090016611A (pt) |
| CN (1) | CN101528202A (pt) |
| BR (1) | BRPI0621789A2 (pt) |
| CA (1) | CA2654523A1 (pt) |
| IL (1) | IL195541A0 (pt) |
| MX (1) | MX2008016568A (pt) |
| NO (1) | NO20090554L (pt) |
| RU (1) | RU2009103658A (pt) |
| WO (1) | WO2008005036A1 (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0623897D0 (en) * | 2006-11-30 | 2007-01-10 | Pliva Istrazivanje I Razvoj D | Pharmaceutical composition of memantine |
| WO2009084017A2 (en) | 2007-10-10 | 2009-07-09 | Rubicon Research Private Limited | Taste-masked orally disintegrating tablets of memantine hydrochloride |
| US20100232659A1 (en) * | 2009-03-12 | 2010-09-16 | Harris Corporation | Method for fingerprint template synthesis and fingerprint mosaicing using a point matching algorithm |
| WO2010112221A1 (en) * | 2009-04-03 | 2010-10-07 | Synthon B.V. | Pharmaceutical compositions comprising memantine |
| GB0913681D0 (en) * | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| JP5714600B2 (ja) * | 2009-12-18 | 2015-05-07 | フリースランドカンピナ・ネーデルランド・ホールディング・ビー．ブイ．ＦｒｉｅｓｌａｎｄＣａｍｐｉｎａ Ｎｅｄｅｒｌａｎｄ Ｈｏｌｄｉｎｇ Ｂ．Ｖ． | 共加工された錠用賦形剤混合物、その調製及び使用 |
| EP4166558A1 (en) * | 2010-02-12 | 2023-04-19 | Pfizer Inc. | Salts and polymorphs of 8-fluoro-2-{4- [(methylamino)methyl]phenyl}-1 ,3,4,5-tetrahydro-6h-azepino[5,4,3- cd]indol-6-one |
| TR201001117A1 (tr) | 2010-02-15 | 2011-09-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Dimebolin ve memantin kombinasyonları |
| RU2483715C2 (ru) * | 2010-12-30 | 2013-06-10 | Общество с ограниченной ответственностью "АКАДЕМФАРМ" | Твердая лекарственная форма препаратов мемантина и его солей |
| US20140004189A1 (en) | 2011-01-25 | 2014-01-02 | Cadila Healthcare Limited | Modified release pharmaceutical compositions memantine |
| RU2484820C2 (ru) * | 2011-02-24 | 2013-06-20 | Общество с ограниченной ответственностью "Озон" | Комбинированное лекарственное средство, являющееся ингибитором агрегации тромбоцитов |
| HUE051585T2 (hu) * | 2011-10-17 | 2021-03-01 | Lexicon Pharmaceuticals Inc | (S)-etil-2-amino-3-(4-(2-amino-6-((R)-1-(4-klór-2-(3-metil-1H-pirazol-1-il)fenil)-2,2,2- trifluoretoxi)pirimidin-4-il)fenil)propanoát szilárd adagolási formái |
| RU2488388C1 (ru) * | 2012-05-24 | 2013-07-27 | Ооо "Валента Интеллект" | Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств |
| KR101964295B1 (ko) * | 2012-09-05 | 2019-04-01 | 주식회사 한독 | 피부 자극이 감소된 메만틴 경피전달 시스템 |
| UA107653U (uk) | 2012-10-01 | 2016-06-24 | Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" | Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів |
| US11241434B2 (en) | 2013-06-13 | 2022-02-08 | Yale Uninversity | Compositions and methods for improving cognition in a subject |
| US10660957B2 (en) * | 2013-06-13 | 2020-05-26 | Yale University | Compositions and methods for treating an Aβ-modulated disease or disorder or improving cognition in a subject |
| CN104434855B (zh) * | 2014-12-10 | 2017-02-01 | 哈药集团技术中心 | 一种盐酸美金刚片及其制备方法 |
| KR101938872B1 (ko) | 2016-09-30 | 2019-01-16 | 주식회사 바이오파마티스 | 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
| CN107334744B (zh) * | 2017-07-24 | 2020-09-04 | 湖南洞庭药业股份有限公司 | 盐酸美金刚药物组合物和制法 |
| JP7250305B2 (ja) * | 2018-10-02 | 2023-04-03 | 共和薬品工業株式会社 | メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法 |
| WO2020075024A1 (en) * | 2018-10-12 | 2020-04-16 | Dr. Reddy’S Laboratories Limited | Process for preparation of memantine |
| US12133918B2 (en) | 2021-10-01 | 2024-11-05 | Griffin Gamma, Llc | Partially pre-gelatinized cassava starch as pharmaceutical excipient |
| CN114681423B (zh) * | 2022-05-19 | 2024-02-27 | 海南林恒制药股份有限公司 | 一种盐酸美金刚片及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040166159A1 (en) * | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
| MXPA05012810A (es) * | 2003-06-16 | 2006-02-13 | Allergan Inc | Formas de dosis oral de memantina. |
| EP1715843A1 (en) * | 2004-01-29 | 2006-11-02 | Neuromolecular Inc. | Combination of a nmda receptor antagonist and a mao-inhibitor or a gadph-inhibitor for the treatment of central nervous system-related conditions |
| US20050244478A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Anti-excititoxic sustained release intraocular implants and related methods |
| US20060002999A1 (en) * | 2004-06-17 | 2006-01-05 | Forest Laboratories, Inc. | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| TW200616608A (en) * | 2004-07-09 | 2006-06-01 | Forest Laboratories | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients |
| JP2006138227A (ja) * | 2004-11-10 | 2006-06-01 | Toyota Motor Corp | 排ガス浄化装置 |
| CA2588295C (en) * | 2004-11-23 | 2013-10-22 | Adamas Pharma, Llc | Method and composition for administering an nmda receptor antagonist to a subject |
| EP2623099A1 (en) * | 2004-11-24 | 2013-08-07 | Neuromolecular Pharmaceuticals, Inc | Composition and method for treating neurological disease |
| US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| US20060160852A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
| WO2006076562A1 (en) * | 2005-01-11 | 2006-07-20 | Teva Pharmaceutical Fine Chemicals S.R.L. | Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride |
| ATE481096T1 (de) * | 2005-04-06 | 2010-10-15 | Adamas Pharmaceuticals Inc | Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen |
| EP1898890A1 (en) * | 2005-06-16 | 2008-03-19 | Forest Laboratories, Inc. | Modified and immediate release memantine bead formulation |
| EP2040676A2 (en) * | 2006-07-06 | 2009-04-01 | Forest Laboratories, Inc. | Orally dissolving formulations of memantine |
-
2006
- 2006-09-20 WO PCT/US2006/036628 patent/WO2008005036A1/en not_active Ceased
- 2006-09-20 CA CA002654523A patent/CA2654523A1/en not_active Abandoned
- 2006-09-20 JP JP2009518087A patent/JP2009542647A/ja active Pending
- 2006-09-20 KR KR1020087032250A patent/KR20090016611A/ko not_active Ceased
- 2006-09-20 EP EP06254865A patent/EP1886670A1/en not_active Ceased
- 2006-09-20 CN CNA2006800551559A patent/CN101528202A/zh active Pending
- 2006-09-20 MX MX2008016568A patent/MX2008016568A/es unknown
- 2006-09-20 BR BRPI0621789-3A patent/BRPI0621789A2/pt not_active IP Right Cessation
- 2006-09-20 RU RU2009103658/15A patent/RU2009103658A/ru unknown
- 2006-09-20 US US11/524,778 patent/US20080008752A1/en not_active Abandoned
-
2008
- 2008-11-26 IL IL195541A patent/IL195541A0/en unknown
-
2009
- 2009-02-04 NO NO20090554A patent/NO20090554L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008005036A1 (en) | 2008-01-10 |
| US20080008752A1 (en) | 2008-01-10 |
| JP2009542647A (ja) | 2009-12-03 |
| CA2654523A1 (en) | 2008-01-10 |
| RU2009103658A (ru) | 2010-08-10 |
| KR20090016611A (ko) | 2009-02-16 |
| IL195541A0 (en) | 2009-09-01 |
| BRPI0621789A2 (pt) | 2012-05-02 |
| EP1886670A1 (en) | 2008-02-13 |
| CN101528202A (zh) | 2009-09-09 |
| MX2008016568A (es) | 2009-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20090554L (no) | Farmasoytiske preparater av memantin | |
| JOP20180109A1 (ar) | تركيبة جديدة | |
| TW200711652A (en) | Method and composition for pharmaceutical product | |
| ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
| JO3406B1 (ar) | عملية لتصنيع منتج صيدلاني يشتمل على حمض الستريك ،أكسيد ماغنسيوم، بيكربونات بوتاسيوم وبيكو كبريتات صوديوم، تركيبة صيدلانية تشتمل على حبيبات متحصل عليها بواسطة هذه العملية ومنتجات وسيطة منها | |
| UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
| UA93353C2 (ru) | Производство фармацевтических композиций c быстрым высвобождением ha ochobe водонерастворимых лекарсвенных средств и фармацевтические композиции, полученные способом согласно изобретению | |
| UA91848C2 (ru) | Применение соединений диосметина в лечении и предотвращении тромботическим патологиям | |
| WO2009032843A3 (en) | Deuterated ethambutols and their use | |
| HK1214519A1 (zh) | 雙用途硫酸鹽口服藥物組合物片劑及其使用方法 | |
| TW200744672A (en) | Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily | |
| NO20070187L (no) | Oralt desintegrerende farmasoytisk preparat omfattende risperidon | |
| NO20076120L (no) | Stabile nanopartikkelformuleringer | |
| WO2009084036A3 (en) | Composition for treatment of viral infections | |
| IL191670A0 (en) | Compounds for the inhibition of apoptosis | |
| IL191992A0 (en) | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications | |
| DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1979321T3 (da) | Nye pyridinylaminoalkylen- og pyridinyloxyalkylen-cyclopropanaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dissse | |
| DK1742927T3 (da) | Butanonsyrederivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater omfattende dem, og farmaceutiske applikationer deraf | |
| GT200600119A (es) | Composiciones farmaceuticas | |
| DK1818048T3 (da) | Farmaceutiske formuleringer af alifatiske aminpolymerer og metoder til deres fremstilling | |
| GB0615105D0 (en) | Novel compounds | |
| MX374707B (es) | Comprimidos de ibuprofeno de sodio y procedimientos de fabricacion de composiciones farmaceuticas que incluyen ibuprofeno de sodio. | |
| DK1853220T3 (da) | Fremgangsmåde til fremstilling af tabletter indeholdende inflammationshæmmende non-steroid-lægemiddel, deres sammensætninger og medicinske anvendelse | |
| ATE438381T1 (de) | Zolpidemtabletten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |